Ali Hamzehloo

Summary

Publications

  1. ncbi Mitoxantrone reduced disability in Iranian patients with multiple sclerosis
    Ali Hamzehloo
    Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
    Arch Iran Med 10:59-64. 2007
  2. ncbi Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis
    Ali Hamzehloo
    Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
    Arch Iran Med 9:111-4. 2006

Detail Information

Publications2

  1. ncbi Mitoxantrone reduced disability in Iranian patients with multiple sclerosis
    Ali Hamzehloo
    Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
    Arch Iran Med 10:59-64. 2007
    ..This study aimed to assess the efficacy of mitoxantrone on disease activity and decreasing relapse rate in patients with multiple sclerosis in Iran...
  2. ncbi Mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis
    Ali Hamzehloo
    Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
    Arch Iran Med 9:111-4. 2006
    ..Mitoxantrone is an antineoplastic drug, recently approved for treatment of multiple sclerosis. Mitoxantrone is, however, associated with dose-related cardiotoxicity, which limits its use...